Immune tolerance induction with Octanate® in haemophilia A patients with inhibitors and a poor prognosis: progress report on an ongoing prospective data collection

被引：0
|
作者：
Zozulya, N. [1 ]
Plyushch, O. [1 ]
Vdovin, V. [2 ]
Svirin, P. [2 ]
Andreeva, T. [3 ]
Dolnicar, M. Benedik [4 ]
Severova, T. [1 ]
Klimova, N. [3 ]
Escuriola, C. [5 ]
Kreuz, W. [5 ]
机构：
[1] Haematol Sci Ctr RAMS, Moscow, Russia
[2] Izmailovskiy Children Hosp, Moscow, Russia
[3] St Petersburg City Hemophilia Treatment Ctr, St Petersburg, Russia
[4] Univ Childrens Hosp, Haematooncol Dept, Natl Haemophilia Ctr, Ljubljana, Slovenia
[5] Johann Wolfgang Goethe Univ Hosp, Frankfurt, Germany
来源：
HAEMOPHILIA | 2010年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [1] The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and poor prognosis:: prospective post-marketing study in progress
    Zozulya, N.
    Plyushch, O.
    Severova, T.
    HAEMOPHILIA, 2008, 14 : 51 - 51
  • [2] The Octanate® immune tolerance induction experience in haemophilia A patients with inhibitors and a poor prognosis:: prospective post-marketing study in progress
    Zozulya, N. I. .
    Plyushch, O. P.
    Severova, T. V.
    HAEMOPHILIA, 2008, 14 : 150 - 150
  • [3] ITI with a VWF/FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on Octanate in the Obsiti study
    Zozulya, N.
    Plyushch, O.
    Vdovin, V.
    Andreeva, T.
    Svirin, P.
    Severova, T.
    Shiller, E.
    Klimova, N.
    Dolnicar, M. B.
    Velasco, F.
    Campos, M.
    Morais, S.
    Ettingshausen, C. E.
    Kreuz, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 825 - 826
  • [4] ITI with a VWF/FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on OCTANATE® in the obsiti study
    Escuriola-Ettingshausen, C.
    Kreuz, W.
    HAEMOPHILIA, 2013, 19 : 48 - 49
  • [5] Treatment of haemophilia A patients with inhibitors and a poor prognosis: ITI with octanate® Zozulya NI
    Zozulya, N., I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 1127 - 1127
  • [6] Immune tolerance induction with antihaemophilia factor (human) in poor prognosis patients with haemophilia A
    Escobar, Miguel
    Shaffer, Linda
    Holguin, Mark
    McCavit, Timothy
    Amega, Novinyo S.
    Rajan, Sandeep K.
    HAEMOPHILIA, 2021, 27 (03) : E393 - E397
  • [7] ITI with a VWF stabilised FVIII concentrate in haemophilia A patients with inhibitors and a poor prognosis for ITI success: progress report on Octanate® in the observational ObsITI study
    Ettingshausen, C. Escuriola
    Zozulya, N.
    Plyushch, O.
    Vdovin, V.
    Andreeva, T.
    Svirin, P.
    Severova, T.
    Shiller, E.
    Klimova, N.
    Benedik-Dolnicar, M.
    Velasco, F.
    Campos, M.
    Morais, S.
    Kreuz, W.
    HAEMOPHILIA, 2012, 18 : 13 - 14
  • [8] ITI with a VWF-stabilised FVIII concentrate in haemophilia a patients with inhibitors and a poor prognosis for ITI success: progress report on octanate in the observational obsiti study
    Zozulya, N.
    Plysch, O.
    Vdovin, V.
    Andreeva, T.
    Svirin, P.
    Severova, T.
    Shiller, E.
    Klimova, N.
    Benedik-Dolnicar, M.
    Velasco, F.
    Campos, M.
    Bichler, J.
    Escuriola, C.
    Kreuz, W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 30 - 31
  • [9] ITI with a VWF-Stabilised FVIII Concentrate in Haemophilia A Patients with Inhibitors and a Poor Prognosis form ITI Success: Progress Report on octanate® in the Observational ObsITI Study
    Escuriola-Ettingshausen, Carmen
    Vdovin, Vladimir
    Zozulya, Nadezhda
    Plyushch, Olga
    Kreuz, Wolfhart
    Schwartz, Bruce A.
    BLOOD, 2011, 118 (21) : 1423 - 1423
  • [10] ITI with a VWF/FVIII concentrate in haemophilia A patients with inhibitors and a poor prognosis for ITI success: Octanate® in the ObsITI study
    Escuriola, C.
    Kreuz, W.
    Schwartz, B.
    HAEMOPHILIA, 2013, 19 (03) : 466 - 466
12345